Integrated Drug Discovery Projects

Science-led integrated drug discovery

Introduction

BioAscent is a CRO with extensive expertise in the constituent disciplines of drug discovery. We combine these disciplines together to enable effective delivery of fully integrated drug discovery services to our customers. Our scientists work in closely-knit teams on a single site and are accustomed to working closely with customers from around the world to understand what is required, to drive progress and to reach key milestones.

INTEGRATED DRUG DISCOVERY CASE STUDY

Working in collaboration with partners at the German Cancer Research Center within the European Lead Factory project (ELF), BioAscent scientists helped discover potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases.  This work has been published in ChemMedChem.

“More importantly, the scientists who were involved in the hit development stage, were fully committed to the success of the project, bringing their own ideas and solutions, which made my role as project owner very comfortable. I would be very happy to work with them again.”

Dr Aubry Miller, Cancer Drug Discovery/Wirkstoffforschung Group Leader, German Cancer Research Center (DKFZ)

Our Experts

Director of Biosciences

Dr Stuart McElroy

Read more

Director of Chemistry

Dr Angus Morrison

Read more

Chief Operating Officer and Co-founder

Dr Sylviane Boucharens

Read more

Associate Director, In Silico Discovery and Data Analysis

Dr Angelo Pugliese

Read more

Associate Director Biosciences

Dr Brian McFerran

Read more

Associate Director of Chemistry

Dr Duncan McArthur

Read more

Chief Scientific Advisor

Dr Phil Jones

Read more

Integrated Drug Discovery


Science-led drug discovery

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact